Karthik Devarajan, Ph.D.
Affiliations: | 2000 | Northern Illinois University, DeKalb, IL, United States |
Area:
Statistics, Mathematics, Biostatistics BiologyGoogle:
"Karthik Devarajan"Parents
Sign in to add mentorNader Ebrahimi | grad student | 2000 | Northern Illinois University | |
(Inference for a nonproportional hazards regression model and applications.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Asadi M, Devarajan K, Ebrahimi N, et al. (2022) Elaboration Models with Symmetric Information Divergence. International Statistical Review = Revue Internationale De Statistique. 90: 499-524 |
Spirko-Burns L, Devarajan K. (2020) Supervised dimension reduction for large-scale "omics" data with censored survival outcomes under possible non-proportional hazards. Ieee/Acm Transactions On Computational Biology and Bioinformatics |
Rengan AK, Dotan E, Devarajan K, et al. (2020) Genomic associations in metastatic pancreatic cancer (mPC). Journal of Clinical Oncology. 38: 765-765 |
Winn JS, Hasse Z, Pei J, et al. (2020) Abstract P5-03-11: Germline and somatic variants in patients with inflammatory breast cancer (IBC) detected using cell-free DNA Cancer Research. 80 |
Mancuso P, Tricarico R, Bhattacharjee V, et al. (2019) Thymine DNA glycosylase as a novel target for melanoma. Oncogene |
O'Brien SB, Mutabdzic D, Handorf EA, et al. (2019) Stage II and III rectal adenocarcinoma outcomes related to lymphovascular invasion. Journal of Clinical Oncology. 37: 698-698 |
Kozinova M, Joshi S, Devarajan K, et al. (2018) Abstract 4808: Combinations of imatinib mesylate with AKT inhibitor (miransertib, ARQ 751) or FGFR inhibitor (derazantinib) show synergy in GIST cell lines and preclinical models Cancer Research. 78: 4808-4808 |
Ghatalia P, Devarajan K, Gordetsky J, et al. (2018) Abstract 3141: Immune gene expression and prognosis in localized clear cell (cc) renal cell carcinoma (RCC) Cancer Research. 78: 3141-3141 |
Tricarico R, Mancuso P, Bhattacharjee V, et al. (2018) Abstract 1940: Thymine DNA glycosylase (TDG) as a novel target for melanoma Cancer Research. 78: 1940-1940 |
Jiang W, Dulaimi E, Devarajan K, et al. (2017) Intratumoral heterogeneity analysis reveals hidden associations between protein expression losses and patient survival in clear cell renal cell carcinoma. Oncotarget |